StockData
Pharming Group N.V. logo

Pharming Group N.V. (PHAR) income statement

PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 2, 2026Score 8/30
$12.48+0.42 (+3.51%)

Close on Nov 18, 2026Market cap $875.92MP/E 312.1Yield –

Pharming Group N.V. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
87.9%
Operating margin
6.9%
Net margin
0.8%
Return on equity, FY2025
–

Financial strength

Current ratio
2.59
Debt to equity
–
Debt to assets
–
Cash to current liabilities
125.5%

Valuation

P/E ratio
312.1
Price to sales
2.33
Price to book
–
Dividend yield
–

See a number that looks wrong?